<DOC>
	<DOCNO>NCT02660463</DOCNO>
	<brief_summary>The incidence chronic thromboembolic pulmonary hypertension ( CTEPH ) acute pulmonary embolism ist clear . It estimate 3.8 % . Prospective data registration exist . Treatment choice pulmonary endarterectomy thromboembolic lesion surgically accessible . Otherwise interventional therapy mean pulmonary balloon-angioplasty ( BPA ) medical therapy indicate . In Germany , majority patient refer three CTEPH center : Kerckhoff Clinic , Saarland University Hospital Hannover Medical School evaluate therapeutic option . Starting January 2016 incident patient de-identified include prospectively . Risk factor , outcome treatment document .</brief_summary>
	<brief_title>Prospective Registry Evaluate Effective Incidence Chronic Thromboembolic Pulmonary Hypertension Germany</brief_title>
	<detailed_description>All patient refer participate center diagnose standardized manner confirm diagnosis `` CTEPH '' . No additional intervention blood sample necessary . The recommended treatment option result weekly CTEPH conference . Every patient discuss . The registry contain follow data : Center PLZ Sex Age Body Mass Index History venous thromboembolism ( VTE ) , Date ff 1st VTE Anticoagulation type anticoagulation Blood group V/Q scan CT-agiography Pulmonary angiogram World Health Organisation-Functional Class six-minute walk distance Right heart catheter : RAP , PAPs , PAPd , PAPm , PAWP , CO , CI , PVR , SvO2 Treatment : PEA , Ballon Pulmonary Angioplasty ( BPA ) , medically therapy , Vena cava filter CTEPH special risk factor : thrombophilia , antiphospholipid antibody syndrome , splenectomy , VA shunt ; pacemaker</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>diagnosis `` CTEPH '' confirm</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>incidence</keyword>
	<keyword>risk factor</keyword>
</DOC>